Anonymous ID: e61a3b May 19, 2020, 6:23 p.m. No.9246243   🗄️.is 🔗kun   >>6290 >>6553 >>6587 >>6604 >>6827

>>9245948 lb

>>9245963 lb

>>9245995 lb

Wonder if this family still owns a chunk?

If so, that would explain a lot.

 

https://in.pinterest.com/pin/399061216956974559/

https://web.archive.org/web/20190225114830/https://www.nytimes.com/1992/02/16/us/rockefeller-family-tries-to-keep-a-vast-fortune-from-dissipating.html

So far this year one Rockefeller-backed company, Gilead Sciences of Foster City, Calif., has gone public.

Anonymous ID: e61a3b May 19, 2020, 6:29 p.m. No.9246290   🗄️.is 🔗kun   >>6553 >>6604 >>6827

>>9246243

https://www.marketscreener.com/GILEAD-SCIENCES-4876/news/Gilead-Sciences-Licenses-Portfolio-of-HIV-Antibodies-From-The-Rockefeller-University-29812769/

 

Gilead Sciences, Inc. (NASDAQ: GILD) announced today that the company has licensed The Rockefeller University’s portfolio of broadly neutralizing antibodies (bNAbs) against HIV, including the two clinical-stage agents 3BNC117 and 10-1074. These investigational agents have potential for use in HIV long-acting therapies for treatment and prevention, as well as cure strategies.

 

Under the agreement, Gilead acquires exclusive global licenses to develop and commercialize Rockefeller’s full portfolio of HIV bNAbs. Rockefeller will receive an upfront payment and is eligible to receive cumulative milestone payments, as well as royalties on net sales. Additionally, Rockefeller will retain rights to perform non-clinical and early-stage clinical research on the portfolio of HIV antibodies.